Concepedia

Rose Pitoniak

RP

Statistics

Publications

5

Citations

236

H-Index

5

Active since

2005

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Rose Pitoniak is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, oncology, and pharmacology.

Publications per year

2005–2015

5

Publications

5

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice

Bonnie L. Hylander, Rose Pitoniak, Remedios Penetrante et al. · Journal of Translational Medicine · 2005 · 107 citations · Full text

, , +17

Origin of the vasculature supporting growth of primary patient tumor xenografts

Bonnie L. Hylander, Natalie Punt, Haikuo Tang et al. · Journal of Translational Medicine · 2013 · 78 citations · Full text

, , +16

Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model

Bonnie L. Hylander, Arindam Sen, Sarah H. Beachy et al. · Journal of Controlled Release · 2015 · 25 citations

, , +17

Influence of the Implantation Site on the Sensitivity of Patient Pancreatic Tumor Xenografts to Apo2L/TRAIL Therapy

Rohit Sharma, Sandra Buitrago, Rose Pitoniak et al. · Pancreas · 2014 · 13 citations · Full text

, , +17

Lung cancer xenografting alters microRNA profile but not immunophenotype

Paul N. Bogner, Santosh K. Patnaik, Rose Pitoniak et al. · Biochemical and Biophysical Research Communications · 2009 · 13 citations

, , +12

1–5 of 5